This observational study is looking into the causes and best ways to treat hypoglycemia (low blood sugar). It aims to understand conditions like insulinoma (a tumor in the pancreas that makes too much insulin) and identify new markers in the blood for these conditions. You might be able to join if you are 18 years or older and have documented low fasting blood sugar levels (below 55 mg/dl) or have been diagnosed with insulinoma or other pancreatic neuroendocrine tumors. The study will track how well treatments work, with outcomes measured every 1-3 months. The study is currently recruiting up to 1500 participants.

Study design

This is an observational study aiming to enroll 1500 participants. It is not specified if it is randomized or blinded.

What's involved

You would be admitted to the Clinical Center of the National Institutes of Health for tests, including refraining from eating for a period and having blood drawn for insulin levels and other diagnostic tests.

Compensation

Not stated in the trial record.

Follow-up

Treatment outcomes will be measured every 1-3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.